ÂÜÀòÂÒÂ×

Natasha Bayliss is a Principal Scientist at KalVista Pharmaceuticals, Inc., where contributions have been made since January 2018, following a role as Senior Scientist. Prior experience includes serving as a Higher Scientific Officer and Laboratory Supervisor at The Institute of Cancer Research from May 2008 to November 2017, where leadership was demonstrated as Chairperson of the Scientific Officers Association. Natasha's career began at Huntingdon Life Sciences as a Senior Study Analyst specializing in pharmacokinetics, and earlier as a DNA Analyst at the Forensic Science Service. Educational qualifications include an MSc in Toxicology from the University of Birmingham and a BSc in Pharmacology from The University of Sheffield.